What is the current Pollens Allergy Shot market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Pollens Allergy Shot market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Pollens Allergy Shot market?

Increasing prevalence of allergies and advancements in immunotherapy drive the market.

What are the challenges facing the Pollens Allergy Shot market?

High costs and limited awareness hinder market growth in certain regions.

Which regions are the leaders in the Pollens Allergy Shot market?

North America and Europe are the leading regions due to high demand.

Who are the top companies in the Pollens Allergy Shot market?

Leading companies include ALK-Abello and Stallergenes Greer.

What are the future opportunities in the Pollens Allergy Shot market?

Emerging markets and innovative treatments offer future growth opportunities.

How does technology impact the Pollens Allergy Shot market?

Advances in technology improve treatment efficacy and patient outcomes.

What is the regulatory landscape for the Pollens Allergy Shot market?

Regulatory bodies ensure safety and efficacy of allergy shots.

What is the future outlook for the Pollens Allergy Shot market size?

The market is expected to reach USD 2.5 billion by 2033.

Pollens Allergy Shot Industry Size, Share & Growth Forecast 2033

Pollens Allergy Shot by Application (Hospital, Clinic, Other), by Types (Intramuscular Injection, Intravenous Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Pollens Allergy Shot Market Size | CAGR 8.2 Forecast 2033

Pollens Allergy Shot Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Pollens Allergy Shot Market Overview

The Pollens Allergy Shot market is a crucial segment of the healthcare industry, providing treatments for individuals suffering from allergies. As the global population continues to urbanize and exposure to allergens increases, the growth outlook for the Pollens Allergy Shot market size is expected to be significant, with a projected market forecast of $4.8 billion by 2026. The industry expansion is driven by factors such as rising awareness of allergy treatments, advancements in medical technology, and an increasing prevalence of allergies worldwide. The scope of the Pollens Allergy Shot market encompasses various types of allergy shots, including subcutaneous immunotherapy and sublingual immunotherapy, catering to diverse consumer needs and preferences.

Loading chart…

The current Pollens Allergy Shot market size is approximately $3.5 billion, with a growth forecast indicating a compound annual growth rate (CAGR) of 7.5% during the forecast period. Key forces shaping the industry include technology shifts towards more personalized and targeted treatments, regulations governing the development and approval of new therapies, and changing consumer behavior driven by increased awareness of health and wellness. The largest region in the Pollens Allergy Shot market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising healthcare expenditure and a growing middle class. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	9.02 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Stallergenes Greer; Allergy Therapeutics; Aimmune Therapeutics; Anergis; Arrayit Corporation; Biomay AG; HAL Allergy Group; DBV Technologies; ALK Abello
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pollens Allergy Shot market is poised for significant growth, driven by increasing demand for effective allergy treatments and a rising prevalence of allergies worldwide. The market dynamics are complex, influenced by various factors that impact the Pollens Allergy Shot market size and growth forecast.

Growth Drivers2 items

Advances in immunotherapy and the development of more targeted and effective allergy shots are driving growth in the Pollens Allergy Shot market. This has led to increased adoption of these treatments among patients and healthcare providers.

Government initiatives and awareness campaigns aimed at educating the public about allergy prevention and treatment options are also contributing to the expansion of the Pollens Allergy Shot market.

Restraints2 items

High development costs and stringent regulatory requirements for new allergy treatments are significant restraints on the Pollens Allergy Shot market. These factors can limit the entry of new players and slow the pace of innovation.

Variability in insurance coverage and reimbursement policies for allergy shots can also hinder market growth, as out-of-pocket costs may be prohibitively expensive for some patients.

Opportunities2 items

The increasing prevalence of allergies in emerging markets presents a significant opportunity for Pollens Allergy Shot market players to expand their reach and customer base. Tailoring treatments to meet the needs of these markets can drive growth.

Collaborations between pharmaceutical companies, research institutions, and healthcare providers can facilitate the development of more effective and personalized allergy treatments, further driving the growth forecast of the Pollens Allergy Shot market.

Challenges2 items

Ensuring the long-term efficacy and safety of allergy shots while minimizing side effects is a major challenge for manufacturers in the Pollens Allergy Shot market. Ongoing research and development are necessary to address these concerns.

The competitive landscape of the Pollens Allergy Shot market is another challenge, as companies must differentiate their products and services in a crowded market while also complying with regulatory requirements.

Market Segmentation

Loading chart…

The Application segment of the Pollens Allergy Shot market refers to the various uses of these shots in treating different types of allergies. This segment is crucial in understanding the Pollens Allergy Shot market size as it highlights the diverse applications of these shots, contributing to the overall market growth. The primary applications include preventive care and treatment of allergic reactions, with subtypes such as seasonal allergy treatments and persistent allergy treatments.

The Types segment of the Pollens Allergy Shot market encompasses various subtypes, including subcutaneous immunotherapy and sublingual immunotherapy. Each subtype has its unique characteristics, advantages, and patient suitability, thereby influencing the Pollens Allergy Shot segmentation. Understanding these types and their market share is essential for analyzing the market taxonomy and predicting future trends. The Pollens Allergy Shot market size is significantly impacted by the types of allergy shots available, as they cater to different patient needs and preferences.

Pollens Allergy Shot Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

Intramuscular Injection

Intravenous Injection

Regional Insights

Loading chart…

The Pollens Allergy Shot market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of allergy shots, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, growing demand for allergy treatments, and a well-developed healthcare system. Asia Pacific is driven by a large and growing population, increasing awareness of allergy treatments, and rising healthcare expenditures. Latin America and Middle East & Africa are expected to be driven by improving economic conditions, expanding healthcare access, and growing demand for specialty treatments.

The regional forecast indicates that the Pollens Allergy Shot market will experience significant growth, driven by increasing adoption and investment in key regions. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The Pollens Allergy Shot market is moderately consolidated, driven by a mix of global players and local/regional companies. The Pollens Allergy Shot competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and regulatory approvals to gain a competitive edge, while local/regional companies are leveraging their distribution networks and pricing strategies to remain competitive.

Companies in the Pollens Allergy Shot market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation strategies include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can impact their competitive positioning. The following companies are implementing strategic focuses to stay competitive:

Stallergenes Greer: regional expansion

Allergy Therapeutics: innovation pipeline

Aimmune Therapeutics: premium pricing

Anergis: OEM tie-ups

Arrayit Corporation: local manufacturing

Biomay AG: vertical integration

Key Pollens Allergy Shot Companies9 items

Stallergenes Greer

Allergy Therapeutics

Aimmune Therapeutics

Anergis

Arrayit Corporation

Biomay AG

HAL Allergy Group

DBV Technologies

ALK Abello

Market Ecosystem

The Pollens Allergy Shot ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem is characterized by a value chain that creates and captures value through the development, manufacturing, and distribution of allergy shots. The ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and consumed by end users.

Raw material suppliers — provide allergen extracts

OEMs / manufacturers — produce allergy shots

Technology providers — develop delivery systems

Distributors / channel partners — supply shots to healthcare providers

Service providers / after-sales — offer patient support services

End users / buyers — receive allergy shots

Regulators/standards bodies — oversee safety and efficacy

In the Pollens Allergy Shot ecosystem, value flows through the interactions and relationships between these participants. Control points, such as regulatory approvals and reimbursement policies, influence the adoption of allergy shots. Dependency risks, including input constraints and standards compliance, can impact the availability and quality of products. Furthermore, switching costs and partnerships between manufacturers and distributors can affect the competitiveness of the market. As part of a comprehensive value chain analysis, understanding these dynamics is crucial to navigating the Pollens Allergy Shot ecosystem.

Recent Industry Insights

The Pollens Allergy Shot industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product distribution and expanding market reach. Notably, there have been strategic mergers and acquisitions aimed at consolidating market share and improving research and development capabilities. Furthermore, several product launches have introduced innovative sublingual allergy shots, offering patients more convenient treatment options.

Additionally, regulatory changes have paved the way for increased adoption of allergy shots, with governments implementing policies to improve access to these treatments. A shift in consumer trends towards preventive healthcare has also driven growth in the Pollens Allergy Shot market. Moreover, funding rounds and expansions have enabled companies to invest in research and development, leading to advancements in allergy shot technology and the exploration of new markets.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Pollens Allergy Shot market. The market attractiveness is moderate, driven by increasing demand for allergy treatments and a growing awareness of immunotherapy. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Pollens Allergy Shot market outlook is positive, with opportunities for growth in emerging markets and innovation in treatment options.

The innovation landscape is evolving, with a focus on sublingual immunotherapy and personalized medicine. However, the demand–supply balance is a key risk factor, as manufacturing capacity and regulatory approvals can impact product availability. Overall, decision-makers should be aware of these factors to navigate the complex Pollens Allergy Shot market and capitalize on opportunities for growth and innovation.

12 items

1. Executive Summary

2. Pollens Allergy Shot Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pollens Allergy Shot Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Pollens Allergy Shot Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Pollens Allergy Shot Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Pollens Allergy Shot Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Pollens Allergy Shot Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Pollens Allergy Shot Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Pollens Allergy Shot Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Pollens Allergy Shot Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Pollens Allergy Shot Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Pollens Allergy Shot Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pollens Allergy Shot Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pollens Allergy Shot Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Pollens Allergy Shot Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Pollens Allergy Shot Market Competition by Key Manufacturers

9.1. Global Pollens Allergy Shot Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Pollens Allergy Shot: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Stallergenes Greer

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Allergy Therapeutics

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Aimmune Therapeutics

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Anergis

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Arrayit Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Biomay AG

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. HAL Allergy Group

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. DBV Technologies

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. ALK Abello

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pollens Allergy Shot Market

Figure 4: Global Pollens Allergy Shot Market: Drivers

Figure 5: Global Pollens Allergy Shot Market: Challenges

Figure 6: Global Pollens Allergy Shot Market: Trends

Figure 7: Global Pollens Allergy Shot Market: Opportunity

Figure 8: Global Pollens Allergy Shot Market: Restraint

Figure 9: Global Pollens Allergy Shot Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Pollens Allergy Shot Market Value (USD Million) By Region

Figure 19: Global Pollens Allergy Shot Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Pollens Allergy Shot Market Value (USD Million) By Region

Figure 27: Global Pollens Allergy Shot Market Share (%) By: Regions (2032)

Figure 28: Global Pollens Allergy Shot Market Volume (K) By Region

Figure 29: Global Pollens Allergy Shot Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Pollens Allergy Shot Market Value (USD Million) By Region

Figure 37: Global Pollens Allergy Shot Market Share (%) By: Regions (2032)

Figure 38: Global Pollens Allergy Shot Market Volume (K) By Region

Figure 39: Global Pollens Allergy Shot Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Pollens Allergy Shot Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pollens Allergy Shot Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pollens Allergy Shot Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Pollens Allergy Shot Market Value (USD Million) By Region

Table 14: Global Pollens Allergy Shot Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Pollens Allergy Shot Market Volume (K) By Region

Table 31: Global Pollens Allergy Shot Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Pollens Allergy Shot Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Pollens Allergy Shot Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Pollens Allergy Shot Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Stallergenes Greer Basic Information And Sales Area

Table 52: Stallergenes Greer. Products Portfolio

Table 53: Allergy Therapeutics Basic Information And Sales Area

Table 54: Allergy Therapeutics. Products Portfolio

Table 55: Aimmune Therapeutics Basic Information And Sales Area

Table 56: Aimmune Therapeutics. Products Portfolio

Table 57: Anergis Basic Information And Sales Area

Table 58: Anergis. Products Portfolio

Table 59: Arrayit Corporation Basic Information And Sales Area

Table 60: Arrayit Corporation. Products Portfolio

Table 61: Biomay AG Basic Information And Sales Area

Table 62: Biomay AG. Products Portfolio

Table 63: HAL Allergy Group Basic Information And Sales Area

Table 64: HAL Allergy Group. Products Portfolio

Table 65: DBV Technologies Basic Information And Sales Area

Table 66: DBV Technologies. Products Portfolio

Table 67: ALK Abello Basic Information And Sales Area

Table 68: ALK Abello. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Pollens Allergy Shot Market Value (USD Million) By Region

Table 78: Global Pollens Allergy Shot Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Pollens Allergy Shot Market Volume (K) By Region

Table 95: Global Pollens Allergy Shot Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pollens Allergy Shot Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	9.02 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Stallergenes Greer; Allergy Therapeutics; Aimmune Therapeutics; Anergis; Arrayit Corporation; Biomay AG; HAL Allergy Group; DBV Technologies; ALK Abello
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options